Global Epinephrine Injection Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Epinephrine Injection Market Research Report 2024
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
According to Mr Accuracy reports new survey, global Epinephrine Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Epinephrine Injection market research.
Key companies engaged in the Epinephrine Injection industry include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Epinephrine Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Epinephrine Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Epinephrine Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Anaphylaxis
Cardiac Arrest
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Epinephrine Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
According to Mr Accuracy reports new survey, global Epinephrine Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Epinephrine Injection market research.
Key companies engaged in the Epinephrine Injection industry include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Epinephrine Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Epinephrine Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Epinephrine Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Segment by Application
Anaphylaxis
Cardiac Arrest
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Epinephrine Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source